OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Jeffrey Cummings

7 Projects | 1 Researchers | $5,078,262 Invested

2024

University of Nevada Las Vegas

Jeffrey Cummings, MD

Alzheimer's Disease Biomarker Observatory (BMO): Biomarker Data Capture, Curation, and Provision of Access

  • Funding Amount: $3,247,762
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Other
  • Status: Active

2019

Cleveland Clinic Lou Ruvo Center for Brain Health

Jeffrey Cummings, MD

2019 Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery: Rasagiline Rescue in Alzheimer’s Disease Clinical Trial (R2 Trial) – Biomarker add-on funding

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2019

University of Nevada Las Vegas

Jeffrey Cummings, MD

2019 Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery: Rasagiline Rescue in Alzheimer’s Disease Clinical Trial (R2 Trial) – Biomarker add-on funding

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Active

2014

Cleveland Clinic Lou Ruvo Center for Brain Health

Jeffrey Cummings, MD

Rasagiline Rescue in Alzheimer's Disease Clinical Trial (R2 Trial) - add on funding

  • Funding Amount: $228,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2013

Cleveland Clinic Lou Ruvo Center for Brain Health

Jeffrey Cummings, MD

Rasagiline Rescue in Alzheimer's Disease Clinical Trial (R2 Trial)

  • Funding Amount: $1,000,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2011

Cleveland Clinic Lou Ruvo Center for Brain Health

Jeffrey Cummings, MD

Clinical Trials in Frontotemporal Degeneration and Related Disorders

  • Funding Amount: $2,500
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed

2000

University of California, Los Angeles

Jeffrey Cummings, MD

Multicenter Analysis of Hippocampal Morphology in MCI

  • Funding Amount: $300,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed